Dr. Werth is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Spruce Street
2 Rhoads Pavilion
Philadelphia, PA 19104Phone+1 215-662-2737Fax+1 215-349-8339
Education & Training
- NYU Grossman School of MedicineResidency, Dermatology, 1983 - 1986
- McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1980 - 1983
- Johns Hopkins University School of MedicineClass of 1980
Certifications & Licensure
- PA State Medical License 1989 - 2024
- IL State Medical License 1982 - 1984
- MD State Medical License 1980 - 1983
- American Board of Dermatology Dermatology
- American Board of Dermatology Dermatological Immunology/Diagnostic & Laboratory Immunology
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Philadelphia Magazine Castle Connolly, 2008-2014
- America's Top Doctors Castle Connolly, 2008-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
- Join now to see all
Clinical Trials
- Use of Infliximab for the Treatment of Pemphigus Vulgaris Start of enrollment: 2006 Mar 01
- Efficacy of Dapsone as a Steroid Sparing Agent in Pemphigus Vulgaris Start of enrollment: 1996 Nov 01
- Treatment of Cutaneous Lupus Erythematosus (CLE) With the 595 nm Flashlamp Pulsed Dye Laser Start of enrollment: 2007 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- Multiplexed Mass Cytometry of Cutaneous Lupus Erythematosus and Dermatomyositis Skin: An In-depth, B-Cell-Directed Immunoprofile.Mariko Ogawa-Momohara, Thomas Vazquez, Felix Chin, Meena Sharma, Joshua Dan
The Journal of Investigative Dermatology. 2025-01-01 - Long-Term Safety and Efficacy of Lenabasum, a Cannabinoid Receptor Type 2 Agonist, in Patients with Dermatomyositis with Refractory Skin Disease: Follow-Up Data from a...Caroline J Stone, Geeta Ahuja, Lais Lopes Almeida Gomes, Joy Poroye, Daniella Forman Faden
JID Innovations. 2025-01-01 - Smoking status is a negative predictor of six-month cutaneous lupus activity trends: a prospective cohort study.Tyler B Cepica, Lillian Xie, Daniella F Faden, Caroline J Stone, Rui Feng
Journal of the American Academy of Dermatology. 2024-12-06
Journal Articles
- Creation and Validation of Classification Criteria for Discoid Lupus ErythematosusScott A Elman, Kara Braudis, Hee Joo Kim, Victoria P Werth, JAMA Dermatology
- Fatigue in Systemic Lupus Erythematosus and Other Autoimmune Skin DiseasesV P Werth, D Pearson, C J Kushner, The British Journal of Dermatology
- Systemic Sclerosis: Current Concepts of Skin and Systemic ManifestationsDavid R Pearson, Victoria P Werth, ScienceDirect
- Join now to see all
Authored Content
- Creation and Validation of Classification Criteria for Discoid Lupus ErythematosusJune 2020
- Creation and Validation of Classification Criteria for Discoid Lupus ErythematosusJune 2020
- Creation and Validation of Classification Criteria for Discoid Lupus ErythematosusJune 2020
Press Mentions
- Iberdomide Shows Promise for Cutaneous Lupus in Phase 2 StudyOctober 31st, 2024
- Type I IFNs in Cutaneous Lupus & DermatomyositisOctober 14th, 2024
- Among Herbal Supplements, Elderberry Poses Greatest Risks in Autoimmune Skin DiseaseSeptember 24th, 2024
- Join now to see all
Grant Support
- Patient-Oriented Research In Skin Autoimmune DiseaseNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2008–2012
- Assess The Safety Of Pi-0824 In Patients With Pemphigus VulgarisNational Center For Research Resources2005
- Patient-Oriented Research In Skin Autommune DiseaseNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2001–2005
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: